Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Bionor Pharma presents at DNB Healthcare Conference

Financial .2014

CEO Anker Lundemose presented at DNB Healthcare Conference 11 December.

Update from Edison Investment Research

Financial .2014

(Oslo, Norway 01.12.2014) - Edison Investment Research releases updated Bionor Corporate Outlook.

Bionor Pharma Announces that the Combination of Vacc-4x + Revlimid® is Well Tolerated and Increases CD4 Counts in People Living with HIV

Scientific .2014

(Oslo, Norway, 17 November 2014) Bionor Pharma ASA (OSE:BIONOR) announces the results from the Vacc-4x + Revlimid (lenalidomide) study also known as the “Boost & Kill” study. The Phase II trial was an exploratory double-blind placebo controlled immunogenicity study of Vacc-4x + Revlimid versus Vacc-4x in HIV subjects on ART (HIV standard of care treatment).

Bionor Pharma presents at DNB Healthcare Conference

Financial .2014

CEO Anker Lundemose presented at DNB Healthcare Conference 11 December.

Update from Edison Investment Research

Financial .2014

(Oslo, Norway 01.12.2014) - Edison Investment Research releases updated Bionor Corporate Outlook.

Bionor Pharma Announces that the Combination of Vacc-4x + Revlimid® is Well Tolerated and Increases CD4 Counts in People Living with HIV

Scientific .2014

(Oslo, Norway, 17 November 2014) Bionor Pharma ASA (OSE:BIONOR) announces the results from the Vacc-4x + Revlimid (lenalidomide) study also known as the “Boost & Kill” study. The Phase II trial was an exploratory double-blind placebo controlled immunogenicity study of Vacc-4x + Revlimid versus Vacc-4x in HIV subjects on ART (HIV standard of care treatment).

Go to news section

Featured content